The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.00
Bid: 70.60
Ask: 74.00
Change: 0.00 (0.00%)
Spread: 3.40 (4.816%)
Open: 73.00
High: 73.00
Low: 73.00
Prev. Close: 73.00
SFR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Annual General Meeting 2021

1 Sep 2021 11:48

RNS Number : 4005K
Severfield PLC
01 September 2021
 

SEVERFIELD PLC

Results of Annual General Meeting 2021

 

At the Company's Annual General Meeting held at 10 am today, 1 September, all of the resolutions were passed on a show of hands.

Copies of all the resolutions passed have been submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for review at Financial Conduct Authority website (https://data.fca.org.uk/#/nsm/nationalstoragemechanism).

A summary of Proxies received in respect of each resolution is set out below (a "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution):

 

 

 

 

 

 

 

 

 

In Favour

Against

Total

Withheld

 

Resolution

No of votes

% of votes

No of votes

% of votes

No of votes

No of votes

 

1. To receive and adopt the annual accounts and the reports of the Directors for the financial year ended 31 March 2021 together with the report of the auditor thereon.

246,834,634

 

99.99%

 

15,860

 

0.01%

 

246,850,494

 

1,543,484

 

 

2. To approve the Directors' remuneration report (other than the part containing the Directors' remuneration policy) for the financial year ended 31 March 2021 as set out in the Annual Report and Accounts 2021.

248,106,442

 

99.91%

 

232,819

 

0.09%

 

248,339,261

 

54,717

 

 

3. To declare a final dividend of 1.8p per ordinary share in respect of the year ended 31 March 2021 payable on 3rd September 2021 to shareholders on the register at the close of business on 13th August 2021.

248,390,299

 

100.00%

 

221

 

0.00%

 

248,390,520

 

3,458

 

 

4. To reappoint Ian Cochrane as a Director.

248,367,612

 

99.99%

 

21,366

 

0.01%

 

248,388,978

 

5,000

 

 

5. To reappoint Alan Dunsmore as a Director.

248,368,612

 

99.99%

 

16,908

 

0.01%

 

248,385,520

 

8,458

 

 

6. To reappoint Derek Randall as a Director.

248,368,612

99.99%

 

16,908

 

0.01%

 

248,385,520

 

8,458

 

 

7. To reappoint Adam Semple as a Director.

248,371,070

 

99.99%

 

17,908

 

0.01%

 

248,388,978

 

5,000

 

 

8. To reappoint Alun Griffiths as a Director.

248,363,112

 

99.99%

 

22,408

 

0.01%

 

248,385,520

 

8,458

 

 

9. To reappoint Tony Osbaldiston as a Director.

248,357,612

 

99.99%

 

21,908

 

0.01%

 

248,379,520

 

14,458

 

 

10. To reappoint Kevin Whiteman as a Director.

246,030,904

 

99.05%

 

2,348,615

 

0.95%

 

248,379,519

 

14,458

 

 

11. To reappoint Louise Hardy as a Director

248,364,036

 

99.99%

 

18,942

 

0.01%

 

248,382,978

 

11,000

 

 

12. To appoint Rosie Toogood as a Director

248,360,243

 

100.00%

 

11,442

 

0.00%

 

248,371,685

 

22,293

 

 

13. To reappoint KPMG LLP as auditor of the Company to hold office until the conclusion of the next Annual General Meeting of the Company in 2022.

246,805,727

 

99.37%

 

1,568,678

 

0.63%

 

248,374,405

 

19,573

 

 

14. To authorise the Directors to determine the auditor's remuneration.

248,338,050

 

99.99%

 

32,897

 

0.01%

 

248,370,947

 

23,031

 

 

15. To authorise the Directors to allot securities of the Company.

248,013,881

 

99.85%

 

371,639

 

0.15%

 

248,385,520

 

8,458

 

 

16. To authorise the Directors to dis-apply pre-emption rights in relation to the issue of securities of the Company.

248,124,737

 

99.94%

 

157,783

 

0.06%

 

248,282,520

 

111,458

 

 

17. To authorise the Directors to dis-apply pre-emption rights in connection with an acquisition or specified capital investment.

246,670,417

 

99.35%

 

1,612,103

 

0.65%

 

248,282,520

 

111,458

 

 

18. To authorise the Company to make market purchases of the Company's ordinary shares.

246,589,428

 

99.27%

 

1,801,092

 

0.73%

 

248,390,520

 

3,458

 

 

19. That a general meeting of the Company (other than an annual general meeting) may be called on not less than 14 clear days' notice.

247,933,376

 

99.82%

 

457,144

 

0.18%

 

248,390,520

 

3,458

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDKDBQKBKDACK
Date   Source Headline
19th Jan 20211:43 pmRNSIssue of Ordinary Shares
6th Jan 202110:19 amRNSIssue of Ordinary Shares
18th Dec 20203:09 pmRNSDirector/PDMR Shareholding
17th Dec 20203:05 pmRNSDirector/PDMR Shareholding
8th Dec 20201:15 pmRNSDirector/PDMR Shareholding
8th Dec 202012:00 pmRNSIssue of Ordinary Shares
25th Nov 20208:26 amRNSProgressive publishes new research
24th Nov 20203:18 pmRNSAnnouncement of Interim Dividend
24th Nov 20207:00 amRNSInterim Results
17th Nov 202012:18 pmRNSDirector/PDMR Shareholding
20th Oct 20209:45 amRNSBlock Listing Six Monthly Return
19th Oct 20204:25 pmRNSIssue of Ordinary Shares
19th Oct 202012:10 pmRNSDirector/PDMR Shareholding
6th Oct 20207:00 amRNSPayment of bonus and grant of bonus share awards
1st Oct 20207:00 amRNSDirectorate Change
17th Sep 202012:29 pmRNSDirector/PDMR Shareholding
3rd Sep 20204:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:36 pmRNSPrice Monitoring Extension
3rd Sep 20202:09 pmRNSResult of AGM
3rd Sep 202010:58 amRNSProgressive publishes new research
3rd Sep 20207:00 amRNSAGM trading update
18th Aug 20209:44 amRNSDirector/PDMR Shareholding
13th Aug 20203:26 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSDividend Declaration & Notice of AGM
17th Jul 20203:29 pmRNSDirector/PDMR Shareholding
13th Jul 202012:02 pmRNSDirector/PDMR Shareholding
25th Jun 20204:41 pmRNSSecond Price Monitoring Extn
25th Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 202011:21 amRNSIssue of Ordinary Shares
19th Jun 202011:18 amRNSDirector/PDMR Shareholding
17th Jun 20202:26 pmRNSDirector/PDMR Shareholding
17th Jun 20201:27 pmRNSProgressive publishes new research
17th Jun 20207:00 amRNSDirectorate Change
17th Jun 20207:00 amRNSResults for the year ended 31 March 2020
19th May 20203:01 pmRNSDirector/PDMR Shareholding
29th Apr 20204:49 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Apr 20204:11 pmRNSAdditional Listing of Shares
29th Apr 202010:28 amRNSPublication of Articles of Association
21st Apr 20207:00 amRNSPre-close trading update
20th Apr 20209:57 amRNSDirector/PDMR Shareholding
19th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20203:42 pmRNSDirector/PDMR Shareholding
10th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Feb 20205:29 pmRNSDirector/PDMR Shareholding
12th Feb 202012:26 pmRNSHolding(s) in Company
31st Jan 20204:29 pmRNSHolding(s) in Company
29th Jan 20209:13 amRNSDirector/PDMR Shareholding
17th Jan 202011:41 amRNSDirector/PDMR Shareholding
7th Jan 20204:23 pmRNSHolding(s) in Company
19th Dec 201911:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.